This systematic review and meta-analysis synthesizes current preclinical and clinical evidence on mesenchymal stem cell-derived exosomes (MSC-exosomes) for wound healing.
This article synthesizes current evidence on the therapeutic performance of mesenchymal stem cell-derived exosomes (MSC-exosomes) in various animal wound models.
Chronic wounds, characterized by a failure to proceed through an orderly healing process, present a significant clinical challenge.
Diabetic foot ulcers (DFUs) represent a severe complication with high rates of amputation and mortality, driven by a complex microenvironment that often resists conventional care.
This article provides a comprehensive comparative analysis of two prominent classes of extracellular vesicles—small extracellular vesicles (sEVs) and apoptotic vesicles (ApoEVs)—for therapeutic skin regeneration.
Exosome therapy represents a paradigm shift in regenerative medicine, offering a cell-free approach for treating chronic wounds by modulating inflammation, promoting angiogenesis, and stimulating tissue regeneration.
This article provides a comprehensive guide for researchers and drug development professionals on scaling up mesenchymal stem cell (MSC) culture to produce therapeutic exosomes.
This article addresses the critical challenge of high production costs in large-scale, clinical-grade exosome manufacturing, a major barrier to the commercialization of exosome-based therapeutics.
Exosome-based therapeutics represent a paradigm shift in regenerative medicine, offering a cell-free approach for treating chronic wounds.
Exosome-based therapies represent a paradigm shift in regenerative medicine, offering a cell-free approach for promoting wound healing.